OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2019
(2)
2013
(2)
2012
(2)
2017
(1)
2016
(1)
2015
(1)
2014
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.
Not available
S-EPMC3532390
|
biostudies-literature
Cite
Differing von hippel lindau genotype in paired primary and metastatic tumors in patients with clear cell renal cell carcinoma.
Not available
S-EPMC3361062
|
biostudies-literature
Cite
Stillbirth, hypertensive disorders of pregnancy, and placental pathology.
Not available
S-EPMC5893308
|
biostudies-literature
Cite
Stillbirth Collaborative Research Network: design, methods and recruitment experience.
Not available
S-EPMC3665402
|
biostudies-literature
Cite
Fetal growth and risk of stillbirth: a population-based case-control study.
Not available
S-EPMC3995658
|
biostudies-literature
Cite
Karyotype versus microarray testing for genetic abnormalities after stillbirth.
Not available
S-EPMC4295117
|
biostudies-literature
Cite
Altered fetal growth, placental abnormalities, and stillbirth.
Not available
S-EPMC5562325
|
biostudies-literature
Cite
A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans.
Not available
S-EPMC3625065
|
biostudies-literature
Cite
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.
Not available
S-EPMC4676911
|
biostudies-literature
Cite
Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT).
Not available
S-EPMC6804611
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets